23.03.2015

BCS-based biowaiver for Class-III drugs?

Prof. Dr. Henning Blume, SocraTec C&S GmbH
Global Bioequivalence Harmonisation Initiative, EUFEPS, Amsterdam, The Netherlands

 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on single presentations